Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study

References

• Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):593–602.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry. 2007;64(5):543–552.
   PubMed Web of Science ®Google Scholar
• Van Meter A, Moreira ALR, Youngstrom E. Updated meta-analysis of epidemiologic studies of pediatric bipolar disorder. J Clin Psychiatry. 2019;80:18–r12180.
   Web of Science ®Google Scholar
• American Psychiatric Association, editor. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington (DC): American Psychiatric Association; 2013.
   Google Scholar
• Miller S, Dell'Osso B, Ketter TA. The prevalence and burden of bipolar depression. J Affect Disord. 2014;169:S3–S11.
   PubMed Web of Science ®Google Scholar
• Goldstein BI. Recent progress in understanding pediatric bipolar disorder. Arch Pediatr Adolesc Med. 2012;166(4):362–371.
   PubMedGoogle Scholar
• De Crescenzo F, Serra G, Maisto F, et al. Suicide attempts in juvenile bipolar versus major depressive disorders: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(10):825–831.e3.
   PubMed Web of Science ®Google Scholar
• Carbone JT, Holzer KJ, Vaughn MG. Child and adolescent suicidal ideation and suicide attempts: evidence from the healthcare cost and utilization project. J Pediatr. 2019;206:225–231.
   PubMed Web of Science ®Google Scholar
• Cloutier M, Greene M, Guerin A, et al. The economic burden of bipolar I disorder in the United States in 2015. J Affect Disord. 2018;226:45–51.
   PubMed Web of Science ®Google Scholar
• Dusetzina SB, Farley JF, Weinberger M, et al. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatr Serv. 2012;63(10):1019–1025.
   PubMed Web of Science ®Google Scholar
• Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry. 2003;160(7):1286–1290.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.
   PubMed Web of Science ®Google Scholar
• Eli Lilly and Company. Zyprexa (olanzapine) tablets prescribing information [Internet]. U.S. Food & Drug Administration; 2018. [cited 2019 Jun 6]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020592s071,021086s046,021253s059lbl.pdf
   Google Scholar
• Sunovion Pharmaceuticals Inc. Latuda (lurasidone hydrochloride) tablets prescribing information. U.S. Food & Drug Administration; 2018. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/200603s029lbl.pdf
   Google Scholar
• DelBello MP, Goldman R, Phillips D, et al. Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2017;56(12):1015–1025.
   PubMed Web of Science ®Google Scholar
• Post RM, Grunze H. The challenges of children with bipolar disorder. Medicina. 2021;57(6):601.
   PubMed Web of Science ®Google Scholar
• Findling RL, Chang KD. Improving the diagnosis and treatment of pediatric bipolar disorder. J Clin Psychiatry. 2018;79(2):62–69.
   Web of Science ®Google Scholar
• United States Congress. Health Insurance Portability and Accountability Act of 1996. 104–191 [cited 1996 Aug 21]. Available from: http://www.gpo.gov/fdsys/pkg/PLAW-104publ191/html/PLAW-104publ191.htm
   Google Scholar
• Ng-Mak D, Halpern R, Rajagopalan K, et al. Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics. Curr Med Res Opin. 2019;35(2):211–219.
   PubMed Web of Science ®Google Scholar
• Faries DE, Leon AC, Haro JM, et al. Chapter 9 analysis of longitudinal observational data using marginal structural models. In: Anal obs health care data using SAS®. Cary (NC): SAS Institute, Inc.; 2010.
   Google Scholar
• Linden A, Adams JL. Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal data. J Eval Clin Pract. 2010;16(1):180–185.
   PubMed Web of Science ®Google Scholar
• Tunis SL, Ascher-Svanum H, Stensland M, et al. Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs. Pharmacoeconomics. 2004;22(1):1–8.
   PubMed Web of Science ®Google Scholar
• Hedman LC, Petrila J, Fisher WH, et al. State laws on emergency holds for mental health stabilization. Psychiatr Serv. 2016;67(5):529–535.
   PubMed Web of Science ®Google Scholar
• Stensland M, Watson PR, Grazier KL. An examination of costs, charges, and payments for inpatient psychiatric treatment in community hospitals. Psychiatr Serv. 2012;63(7):666–671.
   PubMed Web of Science ®Google Scholar
• Sanchez M, Lytle S, Neudecker M, et al. Medication adherence in pediatric patients with bipolar disorder: a systematic review. J Child Adolesc Psychopharmacol. 2021;31(2):86–94.
   PubMed Web of Science ®Google Scholar
• Feng JY, Toomey SL, Zaslavsky AM, et al. Readmission after pediatric mental health admissions. Pediatrics. 2017;140(6):e20171571.
   PubMed Web of Science ®Google Scholar
• Healy E, Fitzgerald M. A 16-year follow-up of a child inpatient population. Eur Child Adolesc Psychiatry. 2000;9(1):46–53.
   PubMed Web of Science ®Google Scholar
• Goldstein TR, Birmaher B, Axelson D, et al. History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord. 2005;7(6):525–535.
   PubMed Web of Science ®Google Scholar
• Frías Á, Palma C, Farriols N. Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment. J Affect Disord. 2015;174:378–389.
   PubMed Web of Science ®Google Scholar
• Fewell Z, Hernán MA, Wolfe F, et al. Controlling for time-dependent confounding using marginal structural models. The Stata Journal. 2004;4(4):402–420.
   Web of Science ®Google Scholar